** Shares of Lumos Diagnostics Holdings rise as much as 23.4% to A$0.042, set for best day since Jan. 11 - if current gains hold
** Medical equipment manufacturer announces placement of its respiratory test FebriDx on the U.S. MediGroup national contract
** Says MediGroup is single largest non-acute care group purchasing organisaton, which oversees equipment procurement for healthcare providers
** FebriDx evaluates respiratory infection in a patient during emergency care
** Shares hit highest level since Sept 9
** LDX down 44.5% YTD, including day's moves
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
Comments